← Back to Analyst Consensus 
NXTC Buy
NextCure, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 11, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Nov 7, 2025 | Ladenburg Thalmann | upgrade | Neutral → Buy | $18 | 45% |
| Jul 15, 2025 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jul 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Nov 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Aug 2, 2024 | Needham | reiterate | Buy → Buy | $4 | 50% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 3, 2024 | Needham | reiterate | Buy → Buy | $4 | 50% |
| Mar 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Mar 20, 2024 | Needham | maintain | Buy → Buy | $4 | 50% |
| Dec 14, 2023 | Needham | maintain | Buy → Buy | $4 | 50% |
| Aug 8, 2023 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Aug 4, 2023 | Needham | reiterate | Buy → Buy | $6 | 50% |
| May 5, 2023 | Needham | reiterate | — → Buy | $6 | 50% |
| Mar 3, 2023 | Needham | reiterate | — → Buy | $6 | 50% |
| Nov 4, 2022 | Ladenburg Thalmann | downgrade | Buy → Neutral | $0 | 45% |
| Nov 4, 2022 | Needham | maintain | — → Buy | $6 | 50% |
| Nov 4, 2022 | Piper Sandler | maintain | — → Overweight | $6 | 54% |
| Aug 23, 2022 | Truist Securities | maintain | — → Buy | $15 | 54% |
| May 23, 2022 | Piper Sandler | maintain | — → Overweight | $13 | 54% |
| Mar 1, 2022 | Ladenburg Thalmann | initiate | — → Buy | $16 | 45% |
| Nov 5, 2021 | Needham | maintain | — → Buy | $14 | 50% |
| Mar 5, 2021 | Truist Securities | upgrade | Hold → Buy | $19 | 54% |
| Jan 15, 2021 | B of A Securities | downgrade | Neutral → Underperform | $10 | 53% |
| Jul 16, 2020 | Benchmark | upgrade | Hold → Buy | $17 | 54% |
| Jul 14, 2020 | BTIG | maintain | — → Buy | $27 | 52% |
| Jul 13, 2020 | SunTrust Robinson Humphrey | downgrade | Buy → Hold | $13 | — |
| Jun 1, 2020 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| May 8, 2020 | Morgan Stanley | maintain | — → Overweight | $54 | 54% |
| Apr 15, 2020 | Morgan Stanley | maintain | — → Overweight | $58 | 54% |
| Mar 2, 2020 | Roth Capital | initiate | — → Buy | $80 | 53% |
| Jan 13, 2020 | SunTrust Robinson Humphrey | initiate | — → Buy | $78 | — |
| Dec 17, 2019 | Morgan Stanley | maintain | — → Overweight | $55 | 54% |
| Nov 26, 2019 | BTIG | initiate | — → Buy | $61 | 52% |
| Nov 13, 2019 | Morgan Stanley | maintain | — → Overweight | $52 | 54% |
| Nov 12, 2019 | B of A Securities | reiterate | — → Buy | $89 | 53% |
| Sep 9, 2019 | B of A Securities | reiterate | — → Buy | $44 | 53% |
| Sep 5, 2019 | Piper Sandler | maintain | — → Overweight | $54 | 54% |
| Aug 13, 2019 | Morgan Stanley | maintain | — → Overweight | $33 | 54% |
| Jul 9, 2019 | B of A Securities | initiate | — → Buy | $0 | 53% |
| Jun 3, 2019 | Morgan Stanley | initiate | — → Overweight | $25 | 54% |
| Jun 3, 2019 | Piper Sandler | initiate | — → Overweight | $26 | 54% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days